Health Library

KPV

Not FDA-approved

Also known as: Lys-Pro-Val, Alpha-MSH (11–13)

Loading structure…
Structure source: PubChem CID 125672

KPV is a peptide of just three amino acids: lysine, proline and valine. It is the tail end of alpha-MSH, a natural hormone that also calms inflammation. Animal and cell studies suggest it reduces gut and skin inflammation, but it has never been tested in people.

How it works

  • It is the last three amino acids of alpha-MSH. Early mouse work showed this three-amino-acid piece keeps some of the hormone's anti-inflammatory activity.
  • In cell studies, it appears to block the docking step NF-κB needs to enter the cell nucleus (importin-α3). NF-κB is a switch that turns on inflammatory genes.
  • A gut transporter called PepT1 carries it into lining cells. Inflamed colon makes more PepT1, so more KPV may reach inflamed tissue.
  • In animal and cell studies, it lowered the release of inflammatory signaling proteins (cytokines).

Evidence

Gut inflammation (colitis)

Animal and lab studies onlyCEBM Level 5

In two mouse models of colitis, KPV added to drinking water reduced gut inflammation. No human trials have been done or registered.

Skin inflammation

Animal and lab studies onlyCEBM Level 5

In a mouse ear test, KPV reduced inflammatory swelling. It has not been tested on human skin.

Caveats

  • All of the evidence comes from animal (mostly mouse) and cell studies. No human study of any kind has been published.
  • No published animal safety (toxicology) studies were found.
  • The main gut study gave KPV to mice in their drinking water. How that applies to people is unknown.
  • There are no safety data in pregnancy.

References

  1. Dalmasso G, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008.
  2. Hiltz ME, Lipton JM. Antiinflammatory activity of a COOH-terminal fragment of the neuropeptide alpha-MSH. FASEB J. 1989.
  3. Land SC. Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists. Int J Physiol Pathophysiol Pharmacol. 2012.

This page is for education only. It is not medical advice. Decisions about any treatment belong with a physician who knows your history.